Log In
BCIQ
Print this Print this
 

bupivacaine (Exparel) (formerly DepoBupivacaine)

  Manage Alerts
Collapse Summary General Information
Company Pacira Pharmaceuticals Inc.
DescriptionBupivacaine liposome extended-release injectable suspension using DepoFoam drug delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsManage postsurgical pain following total knee arthroplasty; Nerve block; Treat non-surgical pain; Treat postoperative pain; Treat postoperative pain following thoracotomy
Regulatory Designation
PartnerVectura Group plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$43.5M

$1.0M

$42.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/10/2012

$43.5M

$1.0M

$42.5M

Get a free BioCentury trial today